Original article by Jessica Gardner
The Australian Financial Review – Page: 28 : 26-Feb-15

Australian-listed Monash IVF has posted a 2014-15 interim net profit of $A11m, while enquiries from prospective patients rose by four per cent. CEO James Thiedeman forecasts that around 70 per cent of these enquiries will result in new patients for the group. Monash IVF shares closed $A0.05 higher at $A1.405 on 25 February 2015

CORPORATES
MONASH IVF GROUP LIMITED – ASX MVF, FLINDERS FERTILITY